REVIEW PAPER
FAKE MEDICINE – NEW THREATS FOR PUBLIC HEALTH
1, 2,
2,
1
| 1 | Z Narodowego Instytutu Leków w Warszawie |
| 2 | Z Instytutu Pielęgniarstwa i PołoŜnictwa Wydziału Medycznego Uniwersytetu Rzeszowskiego |
Med Og. 2008;14(4)
KEYWORDS
REFERENCES (10)
1.
Cockburn R., Newton P. N., Agyarko E. K., et all.:The global threat of counterfeit drugs: why industry and goverments must communicate the dangers. PloS Medicine 2005, 2 (4), e100.
3.
Gibson L.: Drug regulatory study global treaty to tackle counterfeit drugs BMJ 2004, 328, 486.
5.
Reidenberg M .M., Conner B . A.: Counterfeit and substandard drugs, Clinical Pharmacology & Therapeutics., 2001, 69, 4, 189-193.
6.
Rudolf P .M, Ilisa B. G. BernsteinI. B. G.: Counterfeit drugs. N Engl J Med 2004, 350, 14, 1384-1386.
7.
Wertheimer A . I , Santella T.M.: Counterfeit drugs: defining the problem and finding solutions. Expert Opin. Drug Saf. 2005, 4 (4), 619-622.
8.
Zaracostas J .: WHO to set up international task force on counterfeit drugs., BMJ 2006, 332, 444.
10.
TNS OBOP “Zwyczaje zakupowe Polaków dotyczące nabywania leków” , 17 marca 2004 r. oraz 10 maja 2007.
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.